[1] McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer:their detection and prognostic significance[J]. Br J Cancer, 1996, 73(1):88-95.
[2] Offodile R, Hoh C, Brasky SH, et al. Minimally invasive breast eaneinoma staging using lymphtie mapping with radiolabeled dextrma[J]. Cancer, 1998, 82(9):1704-1708.
[3] Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel node biopsy in breast cancer:Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection[J]. J Am Coll Surg, 1998, 186(3):275-283.
[4] Haffty BG, Ward B, Pathare P, et al. Reappraisal of the role of axillary lymph node dissection in the conservative treastment of breast cancer[J]. J Clin Oncol, 1997, 15(2):691-700.
[5] Glass EC, Essner R, Giuliano AE. Sentinel node localization in breast cancer[J]. Semin Nucl Med, 1999, 29(1):57-68.
[6] Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer[J]. J Clin Oncol, 1997, 15(6):2345-2350.
[7] Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting[J]. Cancer J Sci Am, 1997, 3(6):336-340.
[8] D'Eredita G, Serio G, Mele M, et al. Effect of the use of vital dye, lymphoscintigraphy, or a combination for axillary lymphatic mapping and sentinel node biopsy in breast cancer[J]. World J Surg, 2002, 26(5):592-597.